Insight Medbotics has developed IGAR, the first FDA-cleared robotic system designed for use inside an MRI bore, enabling precise biopsy and therapy delivery in a challenging hospital environment. This technology enhances the accuracy of MRI-guided procedures, allowing for real-time visualization and adaptation of treatment.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
MRI suites present a challenging environment for precise surgical procedures due to strong magnetic fields and confined spaces, which can limit physician maneuverability and the accuracy of manual interventions. Traditional methods for biopsy, therapy delivery, and device placement within an MRI bore often lack the precision needed for optimal targeting and tissue sparing.
Solution
Insight Medbotics addresses these challenges with IGAR, a robotic system designed for seamless integration and operation within the MRI environment. IGAR mounts directly onto the MRI table and facilitates MRI-guided procedures with enhanced accuracy and real-time visualization. The system automates the execution of pre-planned trajectories, increasing physician autonomy while standardizing skill requirements and reducing the physical burden on staff. IGAR's compact, portable design allows it to fit inside standard MRI bores, enabling minimally invasive procedures with precise control. The platform is designed to adapt to future products that can move across different care environments, such as standard operating rooms or physician's offices.
Target Audience
The primary target audience includes radiologists, surgeons, and interventional specialists seeking to improve the precision and efficiency of MRI-guided procedures, as well as hospitals and clinics looking to expand their capabilities in minimally invasive interventions.
Features
- FDA 510(k)-cleared robotic system for use inside 1.5 and 3.0 Tesla MRI environments
- Compact and portable design for seamless integration into existing MRI suites
- Automated trajectory execution for precise and repeatable movements
- Real-time MRI guidance for accurate targeting and adaptation during procedures
- Compatibility with biopsy, therapy delivery, and device placement applications
- Validated in clinical studies with demonstrated safety and efficacy
- Strong IP portfolio with filed applications and issued patents in the US, Canada, and the EU